Journal
NEUROLOGIST
Volume 26, Issue 3, Pages 86-89Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/NRL.0000000000000311
Keywords
stroke; COVID-19; hypercoagulation state; myocardial infarction; thrombolysis
Categories
Ask authors/readers for more resources
The article describes two cases of patients with mild or asymptomatic COVID-19 symptoms who developed acute stroke and concurrent myocardial infarction, despite negative PCR tests but confirmed through serological testing. This suggests that COVID-19 infection may promote the simultaneous occurrence of stroke and myocardial infarction.
Introduction: The concurrency of both, acute stroke and acute myocardial infarction in normal conditions, outside the pandemic is rare. Coagulopathy has been associated with the inflammatory phase of coronavirus disease (COVID-19) and might be involved in this concurrency. Cases Report: We describe 2 patients with previous mild or no symptoms of COVID-19, admitted for acute stroke with recent/simultaneous myocardial infarction in whom admission polymerase chain reaction was negative but serologic testing diagnosed COVID-19. In these patients, concurrent stroke and myocardial infarction could have been promoted by COVID-19 infection. Management and evolution are detailed, and their contacts to confirm the COVID-19 infection. Pathogenic analysis of possible hypercoagulation state is described suggesting the hypothesis of endothelial dysfunction as the strongest mechanism involved in thrombus formation after the acute phase of COVID-19 infection. Conclusions: Our experience with these cases suggests that patients with mild symptoms can also present thromboembolic complications once the acute phase of COVID-19 infection has passed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available